Development of nanoliposomal irinotecan (nal-IRI, MM-398, PEP02) in the management of metastatic pancreatic cancer

Nai Jung Chiang, Jang Yang Chang, Yan Shen Shan, Li Tzong Chen

研究成果: 雜誌貢獻回顧型文獻同行評審

19 引文 斯高帕斯(Scopus)

指紋

深入研究「Development of nanoliposomal irinotecan (nal-IRI, MM-398, PEP02) in the management of metastatic pancreatic cancer」主題。共同形成了獨特的指紋。

Pharmacology, Toxicology and Pharmaceutical Science